Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 1.340 |
| Bid (Size) | 1.340 (300) |
| Ask (Size) | 1.400 (2,700) |
| Prev. Close | 1.340 |
| Today's Range | 1.340 - 1.340 |
| 52wk Range | 0.8621 - 3.780 |
| Shares Outstanding | 142,183,418 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Allogene Q2 Cash Tops $300 Million ↗
August 13, 2025
Allogene Narrows Loss in Fiscal Q2 ↗
August 13, 2025
A Look at Allogene Therapeutics's Upcoming Earnings Report ↗
August 12, 2025
Earnings Scheduled For August 13, 2025 ↗
August 13, 2025
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
Frequently Asked Questions
Is Allogene Therapeutics, Inc. - Common Stock publicly traded?
Yes, Allogene Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Allogene Therapeutics, Inc. - Common Stock trade on?
Allogene Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Allogene Therapeutics, Inc. - Common Stock?
The ticker symbol for Allogene Therapeutics, Inc. - Common Stock is ALLO on the Nasdaq Stock Market
What is the current price of Allogene Therapeutics, Inc. - Common Stock?
The current price of Allogene Therapeutics, Inc. - Common Stock is 1.340
When was Allogene Therapeutics, Inc. - Common Stock last traded?
The last trade of Allogene Therapeutics, Inc. - Common Stock was at 12/02/25 04:00 PM ET
What is the market capitalization of Allogene Therapeutics, Inc. - Common Stock?
The market capitalization of Allogene Therapeutics, Inc. - Common Stock is 190.53M
How many shares of Allogene Therapeutics, Inc. - Common Stock are outstanding?
Allogene Therapeutics, Inc. - Common Stock has 191M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.